Benutzer: Gast  Login
Mehr Felder
Einfache Suche
Titel:

Medical indications and considerations for future clinical decision making.

Dokumenttyp:
Journal Article; Review
Autor(en):
Haas, S
Abstract:
There are many well-known drawbacks associated with the currently used antithrombotic agents, warfarin, heparin, and low-molecular-weight heparins (LMWHs). Because heparins can be administered only parenterally, their application is limited. Though warfarin can be administered orally, its unpredictable anticoagulant effect means that it must be regularly monitored. Ximelagatran (Exanta, AstraZeneca) is a novel, oral direct thrombin inhibitor (oral DTI) that is rapidly converted to its active for...     »
Zeitschriftentitel:
Thromb Res
Jahr:
2003
Band / Volume:
109 Suppl
Seitenangaben Beitrag:
S31-7
Sprache:
eng
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/12818632
Print-ISSN:
0049-3848
TUM Einrichtung:
Institut für Experimentelle Onkologie und Therapieforschung
 BibTeX